MAGGEN AR-CMR registry: use of cardiac magnetic resonance in Argentina

Authors

  • Juan M Bonelli Instituto Gamma - Hospital Privado de Rosario - Hospital Provincial Centenario, Rosario, Santa Fe, Argentina
  • Carlos A Carlessi Hospital JM Cullen - Diagnóstico por Imagen Junín - Sanatorio Garay, Santa Fe, Santa Fe, Argentina
  • Pablo A Bayol Instituto de Cardiología JF Cabral, Corrientes, Argentina
  • Mariana Pierucci Centro de Imágenes Médicas, Rosario, Santa Fe, Argentina
  • Federico Landetta Instituto Radiológico, Mar del Plata, Buenos Aires, Argentina
  • Javier Courtis Instituto Oulton, Córdoba, Córdoba, Argentina
  • Claudio Pereyra Sueldo Clínica privada Vélez Sarsfield, Córdoba, Córdoba, Argentina
  • Jorge Paolasso Sanatorio Allende, Córdoba, Córdoba, Argentina
  • Tomás Vita Instituto Cardiología Rosario - Diagnostico Médico Oroño, Rosario, Santa Fe, Argentina
  • Esteban Sciarresi Clínica de Diagnóstico, San Nicolás, Buenos Aires, Argentina
  • Guillermo E Allende Sanatorio Allende, Córdoba, Córdoba, Argentina

DOI:

https://doi.org/10.63600/1atw3675

Keywords:

Cardiac magnetic resonance, Registry, Argentina, Cardiomyopathy, Gadolinium

Abstract

Introduction: Cardiac magnetic resonance imaging (CMR) is a fundamental tool in the diagnosis of cardiovascular diseases.  The Argentine Registry of Cardiac Magnetic Resonance (IMAGGEN AR-CMR) was designed to obtain information on the use of CMR.

Material and Methods: A prospective registry of patients undergoing CMR was carried out.

Results: 1006 RMC were included. The most frequent indications were non-ischemic cardiomyopathy (55.7%), ischemic heart disease (14.6%).  Macrocyclic gadolinium was used in 61.9% of the studies, with an increase from 54.3% in the period 2018-2020 to 83.5% in the period 2021-2022 (p=< 0.001). 89.7% of the studies had an impact on patient management.  The complication rate was 0.5%.

Conclusions: Non-ischemic cardiomyopathy was the main indication. Macrocyclic gadolinium utilization will be increased during registration. CMR was a safe study with an impact on patient management.

Published

2025-09-30

How to Cite

1.
MAGGEN AR-CMR registry: use of cardiac magnetic resonance in Argentina. Rev. Fed. Arg. Cardiol. [Internet]. 2025 Sep. 30 [cited 2026 Oct. 5];54(3):173-6. Available from: https://www.revistafac.org.ar/ojs/index.php/revistafac/article/view/671